Wolverine Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.81M Hold
109,000
﹤0.01% 1877
2025
Q2
$2.89M Sell
109,000
-27,500
-20% -$724K ﹤0.01% 1415
2025
Q1
$3.5M Buy
136,500
+14,300
+12% +$452K ﹤0.01% 1225
2024
Q4
$4.86M Buy
122,200
+6,900
+6% +$393K ﹤0.01% 1226
2024
Q3
$7.11M Buy
115,300
+49,900
+76% +$2.93M 0.01% 858
2024
Q2
$3.47M Sell
65,400
-21,600
-25% -$1.42M ﹤0.01% 1206
2024
Q1
$7.13M Buy
87,000
+52,200
+150% +$2.32M 0.01% 807
2023
Q4
$648K Buy
34,800
+15,800
+83% +$207K ﹤0.01% 2694
2023
Q3
$210K Sell
19,000
-33,900
-64% -$485K ﹤0.01% 3705
2023
Q2
$826K Sell
52,900
-16,000
-23% -$335K ﹤0.01% 2162
2023
Q1
$1.19M Buy
68,900
+32,600
+90% +$337K ﹤0.01% 1751
2022
Q4
$341K Buy
+36,300
New +$162K ﹤0.01% 2657
2022
Q2
Sell
-12,700
Closed -$39K 5813
2022
Q1
$39K Sell
12,700
-6,700
-35% -$24K ﹤0.01% 5142
2021
Q4
$90K Buy
+19,400
New +$109K ﹤0.01% 5138
2021
Q3
Sell
-17,500
Closed -$108K 7026
2021
Q2
$108K Buy
17,500
+300
+2% +$1.78K ﹤0.01% 5372
2021
Q1
$104K Buy
+17,200
New +$121K ﹤0.01% 5422
2020
Q4
Sell
-22,700
Closed -$135K 5539
2020
Q3
$135K Sell
22,700
-200
-0.9% -$1.38K ﹤0.01% 4027
2020
Q2
$166K Sell
22,900
-8,800
-28% -$58.4K ﹤0.01% 3932
2020
Q1
$150K Buy
+31,700
New +$195K ﹤0.01% 3826
2019
Q4
Sell
-38,600
Closed -$268K 5273
2019
Q3
$268K Buy
+38,600
New +$287K ﹤0.01% 3282
2019
Q1
Sell
-89,000
Closed -$674K 5379
2018
Q4
$674K Sell
89,000
-38,600
-30% -$462K ﹤0.01% 2352
2018
Q3
$2.22M Buy
+127,600
New +$1.52M ﹤0.01% 1572

Other funds holding VKTX